Assessing the function of genetic variants in candidate gene association studies

Nature Reviews Genetics

Volumn 5, Issue 8, 2004, Pages 589-597

  Rebbeck, Timothy R ^a   Spitz, Margaret ^b   Wu, Xifeng ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BIOINFORMATICS; CANDIDATE GENE; EPIDEMIOLOGY; EXPERIMENTATION; EXPOSURE; GENE; GENE FUNCTION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC DISORDER; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW;

ALGORITHMS; ALLELES; CELL LINE; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; CYTOCHROME P-450 ENZYME SYSTEM; EPIDEMIOLOGY, MOLECULAR; EVOLUTION, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; LINKAGE (GENETICS); POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 3442879338     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1403     Document Type: Review

References (59)

1. Cargill, M. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22, 231-238 (1999).
2. Salisbury, B. A. et al. SNP and haplotype variation in the human genome. Mutat. Res. 526, 53-61 (2003).
3. Schneider, J. A. et al. DNA variability of human genes. Mech. Ageing Dev. 124, 17-25 (2003).
4. Schork, N. J., Fallin, D. & Lanchbury, J. S. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin. Genet. 58, 250-264 (2000).
5. Sachidanandam, R. et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928-933 (2001).
6. Zhu, Y. et al. An evolutionary perspective on SNP screening in molecular cancer epidemiology. Cancer Res. 64, 2251-2257 (2004). The first comprehensive evaluation and comparison of SIFT and PolyPhen algorithms in molecular epidemiological association studies.
7. Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33, 177-182 (2003). A comprehensive evaluation of the consistency of association studies that demonstrates the need for functional correlates in achieving consistency in association study results.
8. Botstein, D. & Risch, N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet. 33 (Suppl.), 228-237 (2003).
9. Stoilov, P. et al. Defects in pre-mRNA processing as causes of and predisposition to diseases. DNA Cell Biol. 21, 803-818 (2002).
10. Knight, J. C. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clin. Sci. (Lond.) 104, 493-501 (2003).
11. Li, A. P., Kaminski, D. L. & Rasmussen, A. R. Substrates of human hepatic cytochrome P450 3A4. Toxicology 104, 1-8 (1995).
12. Hashimoto, H. et al. Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers and its transcriptional control. Eur. J. Biochem. 218, 585-595 (1993).
13. Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J. & Malkowicz, S. B. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl Cancer Inst. 90, 1225-1229 (1998).
14. Paris, P. L. et al. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol. Biomarkers Prev. 8, 901-905 (1999).
15. Felix, C. A., et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc. Natl Acad. Sci. 95, 13176-13181 (1998).
16. Kadlubar, F. F. et al. The putative high activity variant, CYP3A4*1B, predicts the onset of puberty in young girls. Cancer Epidemiol. Biomarkers Prev. 12, 327-331 (2003).
17. Lai, J., Vesprini, D., Chu, W., Jernstrom, H. & Narod, S. A. CYP gene polymorphisms and early menarche. Mol. Genet. Metab. 74, 449-457 (2001).
18. Jernstrom, H. et al. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol. Genet. Metab. 72, 144-154 (2001).
19. Lambs, J. K. et al. Common allelic variants in cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics 12, 121-132 (2002).
20. Westlind, A., Lofberg, L., Tindberg, N., Andersson, T. B. & Ingelman-Sundberg, M. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochem. Biophys. Res. Commun. 259, 201-205 (1999).
21. Amirimani, B., Walker, A. H., Weber, B. L. & Rebbeck, T. R. Response: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl Cancer Inst. 91, 1588-1590 (1999).
22. Ando, Y. et al. Re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J. Natl Cancer Inst. 91, 1587-1590 (1999).
23. Spurdle, A. B. et al. The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 12, 355-366 (2002).
24. Floyd, M. D. et al. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics 13, 595-606 (2003).
25. Amirimani B. et al. Transcriptional activity effects of a CYP3A4 promoter variant. Environ. Mol. Mutagen. 42, 299-305 (2003).
26. Hamzeiy, H., Bombail, V., Plant, N., Gibson, G. & Goldfarb, P. Transcriptional regulation of cytochrome P4503A4 gene expression: effects of inherited mutations in the 5′-flanking region. Xenobiotica 33, 1085-1095 (2003).
27. Jeon, J. & An, G. Gene tagging in rice: a high throughput system for functional genomics. Plant Sci. 161, 211-219 (2001).
28. Cecconi, F. & Meyer, B. I. Gene trap: a way to identify novel genes and unravel their biological function. FEBS Lett. 480, 63-71 (2000).
29. Adams, M. D. ENU mutagenesis for pharma. Drug Discov. Today 8, 199-200 (2003).
30. Lee, Y. S. & Mrksich, M. Protein chips: from concept to practice. Trends Biotechnol. 20 (Suppl.), S14-18 (2002).
31. Nikaido, I. et al. EICO (expression-based imprint candidate organizer): finding disease-related imprinted genes. Nucleic Acids Res. 32 (database issue), D548-551 (2004).
32. Knight, J. C., Keating, B. J., Rockett, K. A. & Kwiatkowski, D. P. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nature Genet. 33, 469-475 (2003). The authors report a new method and application of experimental approaches to assessing genotype function.
33. Fay, J. C., Wyckoff, G. J. & Wu, C. I. Positive and negative selection on the human genome. Genetics 158, 1227-1234 (2001).
34. Akey, J. M., Zhang, G., Zhang, K., Jin, L. & Shriver M. D. Interrogating a high-density SNP map for signatures of natural selection. Genome Res. 12, 1805-1814 (2002).
35. Feder, J. N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 13, 399-408 (1996).
36. Nielsen, D. M., Ehm, M. G. & Weir, B. S. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am. J. Hum. Genet. 63, 1531-1540 (1998).
37. Hoh, J., Wille, A. & Ott, J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res. 11, 2115-2119 (2001). The authors propose a novel approach to association studies that incorporates both association and population genetics information in identifying disease genes, including the possibility of genome-wide associations.
38. Perutz, M. F. Structure and function of haemoglobin. I. A tentative atomic model of horse oxyhaemoglobin. J. Mol. Biol. 13, 646-668 (1965).
39. Wang, Z. & Moult, J. Three-dimensional structural location and molecular functional effects of missense SNPs in the T cell receptor Vβ domain. Proteins 53, 748-757 (2003).
40. Wang, Z. & Moult, J. SNPs, protein structure, and disease. Hum. Mutat. 17, 263-270 (2001).
41. Chasman, D. & Adams, R. M. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J. Mol. Biol. 307, 683-706 (2001).
42. Ferrer-Costa, C., Orozco, M. & de la Cruz, X. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J. Mol. Biol. 315, 771-786 (2002).
43. Saunders, C. T. & Baker, D. Evaluation of structural and evolutionary contributions to deleterious mutation prediction. J. Mol. Biol. 322, 891-901 (2002).
44. Herrgard, S. et al. Prediction of deleterious functional effects of amino acid mutations using a library of structure-based function descriptors. Proteins 53, 806-816 (2003).
45. Miller, M. P. & Kumar, S. Understanding human disease mutations through the use of interspecific genetic variation. Hum. Mol. Genet. 10, 2319-2328 (2001).
46. Koref, M. E. S., Gangeswaran, R., Koref, I. P. S., Shanahan, N. & Hancock, J. M. A phylogenetic approach to assessing the significance of missense mutations in disease genes. Hum. Mutat. 22, 51-58 (2003).
47. Krishnan, V. G. & Westhead, D. R. A comparative study of machine-learning methods to predict the effects of single nucleotide polymorphisms on protein function. Bioinformatics 19, 2199-2209 (2003).
48. Ng, P. C. & Henikoff, S. Predicting deleterious amino acid substitutions. Genome Res. 11, 863-874 (2001). An outline of the SIFT approach to assessing missense variant function using evolutionary similarity.
49. Ng, P. C. & Henikoff, S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12, 436-446 (2002).
50. Ng, P. C. & Henikoff, S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812-3814 (2003).
51. Ramensky, V., Bork, P. & Sunyaev, S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30, 3894-3900 (2002). An outline of the PolyPhen methodology for using evolutionary and structure data to assess SNP function.
52. Fleming, M. A., Potter, J. D., Ramirez, C. J., Ostrander, G. K. & Ostrander, E. A. Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc. Natl Acad. Sci. USA 100, 1151-1156 (2003).
53. National Institutes of Health. The ENCODE Project: ENCyclopedia Of DNA Elements [online], 〈http://www.genome.gov/10005107〉 (2003).
54. Rogan, P. K., Svojanovsky, S. & Leeder, J. S. Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics 13, 207-218 (2003).
55. Pagani, F. & Baralle, F. E. Genomic variants in exons and introns: identifying the splicing spoilers. Nature Rev. Genet. 5, 389-396 (2004).
56. Sunyaev, S., Ramensky, V. & Bork, P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet. 16, 198-200 (2000).
57. Sunyaev, S. et al. Prediction of deleterious human alleles. Hum. Mol. Genet. 10, 591-597 (2001).
58. Schuetz, E. G. Lessons from the CYP3A4 promoter. Mol. Pharmacol. 65, 279-281 (2004).
59. Zeigler-Johnson, C. M. et al. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum. Hered. 54, 13-21 (2002).